BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6768567)

  • 1. Haemostatic effects of lysine vasopressin and triglycyl lysine vasopressin infusion in patients with cirrhosis.
    Prowse CV; Douglas JG; Forrest JA; Forsling ML
    Eur J Clin Invest; 1980 Feb; 10(1):49-54. PubMed ID: 6768567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lysine vasopressin and glypressin on the fibrinolytic system in cirrhosis.
    Douglas JG; Forrest JA; Prowse CV; Cash JD; Finlayson ND
    Gut; 1979 Jul; 20(7):565-7. PubMed ID: 488751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled study of glypressin versus vasopressin in the control of bleeding from oesophageal varices.
    Chiu KW; Sheen IS; Liaw YF
    J Gastroenterol Hepatol; 1990; 5(5):549-53. PubMed ID: 1966593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled trial of terlipressin ('Glypressin') versus vasopressin in the early treatment of oesophageal varices.
    Freeman JG; Cobden I; Lishman AH; Record CO
    Lancet; 1982 Jul; 2(8289):66-8. PubMed ID: 6123808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial.
    Söderlund C; Magnusson I; Törngren S; Lundell L
    Scand J Gastroenterol; 1990 Jun; 25(6):622-30. PubMed ID: 2193377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effect of triglycyl-lysine-vasopressin (glypressin) on intravascular oesophageal variceal pressure in patients with cirrhosis. A randomized placebo controlled trial.
    Cestari R; Braga M; Missale G; Ravelli P; Burroughs AK
    J Hepatol; 1990 Mar; 10(2):205-10. PubMed ID: 2185299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Haemodynamic effect of triglycyl-lysine vasopressin (glypressin) on intravascular oesophageal variceal pressure in patients with cirrhosis. A randomized placebo controlled trial].
    Fort E
    Gastroenterol Clin Biol; 1990; 14(11):898-9. PubMed ID: 2276578
    [No Abstract]   [Full Text] [Related]  

  • 8. A discussion of how terlipressin limits mortality in cases of bleeding oesophageal varices.
    Lebrec D
    Eur J Gastroenterol Hepatol; 1998 Jul; 10(7):549-52. PubMed ID: 9855076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of terlipressin in patients with bleeding esophageal varices secondary to cirrhosis of liver.
    Zuberi BF
    J Coll Physicians Surg Pak; 2007 Jun; 17(6):385; author reply 385-6. PubMed ID: 17623601
    [No Abstract]   [Full Text] [Related]  

  • 10. Vasopressin and glypressin in upper gastrointestinal bleeding.
    Söderlund C
    Scand J Gastroenterol Suppl; 1987; 137():50-5. PubMed ID: 2892263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terlipressin for acute esophageal variceal hemorrhage.
    Ioannou G; Doust J; Rockey DC
    Cochrane Database Syst Rev; 2003; (1):CD002147. PubMed ID: 12535432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terlipressin for acute esophageal variceal hemorrhage.
    Ioannou G; Doust J; Rockey DC
    Cochrane Database Syst Rev; 2001; 2003(1):CD002147. PubMed ID: 11279753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomized clinical trial. Liver Study Group of V. Cervello Hospital.
    D'Amico G; Traina M; Vizzini G; Tinè F; Politi F; Montalbano L; Luca A; Pasta L; Pagliaro L; Morabito A
    J Hepatol; 1994 Feb; 20(2):206-12. PubMed ID: 8006401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischaemic colitis in a patient treated with glypressin for bleeding oesophageal varices.
    Schmitt W; Wagner-Thiessen E; Lux G
    Hepatogastroenterology; 1987 Jun; 34(3):134-6. PubMed ID: 3497079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
    Krag A; Borup T; Møller S; Bendtsen F
    Adv Ther; 2008 Nov; 25(11):1105-40. PubMed ID: 19018483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of the triglycyl hormonogen of vasopressin (glypressin) in patients with liver cirrhosis and bleeding esophageal varices.
    Vosmík J; Jedlicka K; Mulder JL; Cort JH
    Gastroenterology; 1977 Apr; 72(4 Pt 1):605-9. PubMed ID: 300062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hemorrhaging esophageal varices with triglycyl lysine vasopressin. Case reports].
    Caletti GC; Brocchi E; Guizzardi G; Bartolucci C; Zani L; Labo' G
    Recenti Prog Med; 1984 Jun; 75(6):566-73. PubMed ID: 6333056
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic effects of terlipressin in patients with bleeding esophageal varices secondary to cirrhosis of liver.
    Badruddin AH; Rasool G; Chaudhry MA
    J Coll Physicians Surg Pak; 2006 Dec; 16(12):755-9. PubMed ID: 17125633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices--final report of a placebo-controlled, double-blind study.
    Walker S; Kreichgauer HP; Bode JC
    Z Gastroenterol; 1996 Oct; 34(10):692-8. PubMed ID: 8921578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terlipressin (glypressin) in the treatment of bleeding esophageal varices. State of the art.
    Soederlund C
    Regul Pept; 1993 Apr; 45(1-2):299-302. PubMed ID: 8511359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.